Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.4, 2009-06, pp. : 313-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controversy over cost effectiveness of drug-eluting stents

Inpharma, Vol. 1, Iss. 1527, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Controversy over cost effectiveness of drug-eluting stents

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 497, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Decision models for assessing the cost effectiveness of drug-eluting stents

By Kong David F Eisenstein Eric L

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 965-974

Informa Healthcare

Access to resources Recommend Favorite

Drug-eluting stents from a European perspective

Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Drug-eluting stents from a European perspective

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite